Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Pesticides can cause reproductive and adrenal health issues.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Cyclophosphamide likely causes skin darkening by affecting hair follicles.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Cyclophosphamide severely damages the intestinal lining in rats.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Finasteride may affect PNMT, causing side effects.

Nilotinib can cause generalized keratosis pilaris.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

High-dose methotrexate can cause severe skin and nail issues.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Mitotane changes steroid breakdown, affecting cortisol availability.

Tacrolimus can cause hair loss in kidney transplant patients.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.